open access

Vol 87, No 6 (2016)
Research paper
Published online: 2016-06-30
Get Citation

Fetal-maternal complications and their association with gestational thrombocytopenia

Vesna Elveđi-Gašparović, Petrana Beljan, Snježana Gverić-Ahmetašević, Snježana Schuster, Snježana Škrablin
DOI: 10.5603/GP.2016.0025
·
Pubmed: 27418224
·
Ginekol Pol 2016;87(6):454-459.

open access

Vol 87, No 6 (2016)
ORIGINAL PAPERS Obstetrics
Published online: 2016-06-30

Abstract

Objectives: Thrombocytopenia is defined as a platelet count of < 150 × 109/L. It is a common hematologic abnormality during pregnancy. Evaluation and treatment of gestational thrombocytopenia can be both, expensive and invasive, and may result in an adverse outcome. The aim of our study was to investigate the incidence of perinatal complications in pregnancies complicated with gestational thrombocytopenia and to determine if the severity of maternal gestational thrombocytopenia implicates unfavorable perinatal outcome.

Material and methods: Over a period of three years, we identified 50 patients with gestational thrombocytopenia: 38 with platelet count between 50–100 × 109/L — classified as moderate thrombocytopenia, and 12 with platelet count of < 50 × 109/L — classified as severe thrombocytopenia. Fifty women with normal platelet count constituted the control group. Maternal complications and neonatal outcomes were compared.

Results: Neonatal thrombocytopenia occurred more often in pregnancies complicated with gestational thrombocytopenia (p = 0.041). Thrombocytopenia in previous pregnancy seems to be an important predicting factor for disease severity in the current pregnancy (p = 0.01).

Conclusions: Gestational thrombocytopenia, even if severe, is not associated with adverse maternal or neonatal outcome. Moderate neonatal thrombocytopenia is more common in pregnancies complicated with severe gestational thrombocytopenia. The incidence of severe gestational thrombocytopenia is higher in patients with thrombocytopenia in previous pregnancy.

Abstract

Objectives: Thrombocytopenia is defined as a platelet count of < 150 × 109/L. It is a common hematologic abnormality during pregnancy. Evaluation and treatment of gestational thrombocytopenia can be both, expensive and invasive, and may result in an adverse outcome. The aim of our study was to investigate the incidence of perinatal complications in pregnancies complicated with gestational thrombocytopenia and to determine if the severity of maternal gestational thrombocytopenia implicates unfavorable perinatal outcome.

Material and methods: Over a period of three years, we identified 50 patients with gestational thrombocytopenia: 38 with platelet count between 50–100 × 109/L — classified as moderate thrombocytopenia, and 12 with platelet count of < 50 × 109/L — classified as severe thrombocytopenia. Fifty women with normal platelet count constituted the control group. Maternal complications and neonatal outcomes were compared.

Results: Neonatal thrombocytopenia occurred more often in pregnancies complicated with gestational thrombocytopenia (p = 0.041). Thrombocytopenia in previous pregnancy seems to be an important predicting factor for disease severity in the current pregnancy (p = 0.01).

Conclusions: Gestational thrombocytopenia, even if severe, is not associated with adverse maternal or neonatal outcome. Moderate neonatal thrombocytopenia is more common in pregnancies complicated with severe gestational thrombocytopenia. The incidence of severe gestational thrombocytopenia is higher in patients with thrombocytopenia in previous pregnancy.

Get Citation

Keywords

gestational thrombocytopenia, neonatal thrombocytopenia, perinatal outcome, platelet count

About this article
Title

Fetal-maternal complications and their association with gestational thrombocytopenia

Journal

Ginekologia Polska

Issue

Vol 87, No 6 (2016)

Article type

Research paper

Pages

454-459

Published online

2016-06-30

DOI

10.5603/GP.2016.0025

Pubmed

27418224

Bibliographic record

Ginekol Pol 2016;87(6):454-459.

Keywords

gestational thrombocytopenia
neonatal thrombocytopenia
perinatal outcome
platelet count

Authors

Vesna Elveđi-Gašparović
Petrana Beljan
Snježana Gverić-Ahmetašević
Snježana Schuster
Snježana Škrablin

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk
tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl